News

AI4Beginners on MSN19h
Modernizing Biotech Compliance: Inside the Transformation of Enterprise Validation Systems
In the highly regulated world of life sciences, quality isn’t a box to check—it’s a business imperative. For global en ...
Gilead Sciences Inc. stock underperforms Friday when compared to competitors
The stock's fall snapped a two-day winning streak.
StockStory.org on MSN20h
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions ...
S&P 500 and Nasdaq composite pull back from their all-time highs
Stocks closed lower on Wall Street, pulling the S&P 500 and the Nasdaq composite below the records they set a day earlier.
Marietta Times10h
U.S. stocks decline, S&P 500 back from its record
U.S. stocks are mostly lower in afternoon trading Friday, pulling the market back from all-time highs, as the Trump ...
US stocks move lower and pull S&P 500 back from its record
U.S. stocks are down in morning trading Friday, pulling the market back from all-time highs, as the Trump administration ...
LancasterOnline22h
US stocks mostly decline, pull S&P 500 back from its record
Stocks are mostly lower on Wall Street, pulling the S&P 500 and the Nasdaq composite below the records they set a day earlier ...
US stocks decline, pull S&P 500 back from its record
U.S. stocks are lower in afternoon trading Friday, pulling the market back from all-time highs, as the Trump administration ...
Zacks Investment Research on MSN23h
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...